Eupraxia re-elects board and re-appoints auditor at AGM

1 min read     Updated on 20 Jun 2026, 01:37 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Eupraxia Pharmaceuticals Inc. re-elected all seven director nominees proposed by management at its Annual General Meeting held on June 18, 2026. Shareholders also re-appointed KPMG LLP as the company's auditor for the ensuing year and authorized the board to fix the remuneration of the auditors.

powered bylight_fuzz_icon
43445246

*this image is generated using AI for illustrative purposes only.

Eupraxia Pharmaceuticals Inc. re-elected all seven director nominees proposed by management at its Annual General Meeting held on June 18, 2026. The voting results confirmed the appointment of the board members, who will remain in office until the next annual meeting or until their successors are elected or appointed.

Election of Directors

All items of business were passed by the shareholders at the meeting. The election of directors was conducted via ballot vote. The detailed voting results for the seven nominees are as follows:

Board of Directors Votes in Favour Votes Withheld
Number of Votes Percentage (%) Number of Votes Percentage (%)
James A. Helliwell 19,815,199 99.784 42,865 0.216
Simon Pimstone 18,091,080 91.102 1,766,984 8.898
Richard M. Glickman 19,443,941 97.915 414,123 2.085
John Montalbano 19,470,318 98.047 387,746 1.953
Joseph Freedman 19,828,021 99.849 30,043 0.151
Amy Pott 19,828,243 99.850 29,821 0.150
Robert Bazemore 19,853,021 99.975 5,043 0.025

Auditor Appointment

In addition to the director elections, shareholders re-appointed KPMG LLP as the auditor of the company for the ensuing year. The resolution also authorized the board to fix the remuneration of the auditors.

What strategic priorities will the re-elected board focus on in the coming year?

How might the high shareholder approval levels influence future governance decisions?

What impact will the re-appointment of KPMG LLP have on the company's financial transparency?

like15
dislike
Must Read Next

Earnings

Corporate Actions

Stocks